Petri Salvén
- Oncology top 1%
- Lymphatic System and Diseases 14
- Vascular Tumors and Angiosarcomas 11
- Cancer Cells and Metastasis 4
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 5
- Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer 37
- Genetics top 2%
- Mesenchymal stem cell research 4
- Immunology and Allergy top 5%
-
- Lymphoma Diagnosis and Treatment 7
-
- Glaucoma and retinal disorders 3
Petri Salvén
49 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 105
- Oncology 2.4k
- Cancer Research 1.1k
- Molecular Biology 3.4k
- Genetics 507
- Immunology and Allergy 204
Countries citing papers authored by Petri Salvén
This map shows the geographic impact of Petri Salvén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Salvén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Salvén more than expected).
Fields of papers citing papers by Petri Salvén
This network shows the impact of papers produced by Petri Salvén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Salvén. The network helps show where Petri Salvén may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Petri Salvén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 24 | |
| 2 | 2013 | 6 | |
| 3 | 2012 | 122 | |
| 4 | 2012 | 29 | |
| 5 | 2010 | 51 | |
| 6 | 2009 | 28 | |
| 7 | 2008 | 294 | |
| 8 | 2002 | 25 | |
| 9 | 2002 | 9 | |
| 10 | 2001 | 16 | |
| 11 | Interferon alpha-2a therapy in 18 hemangioblastomas. | 2001 | 32 |
| 12 | 2000 | 12 | |
| 13 | 1999 | 460 | |
| 14 | 1999 | 103 | |
| 15 | 1998 | 277 | |
| 16 | Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation | 1998 | 2 |
| 17 | 1998 | 232 | |
| 18 | 1997 | 121 | |
| 19 | 1997 | 231 | |
| 20 | 1996 | 43 |
About Petri Salvén
Petri Salvén is a scholar working on Oncology, Molecular Biology and Internal Medicine, having authored 50 papers that have together received 5.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (37 papers), Lymphatic System and Diseases (14 papers), Vascular Tumors and Angiosarcomas (11 papers), Lymphoma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Cells and Metastasis (4 papers), Mesenchymal stem cell research (4 papers) and Glaucoma and retinal disorders (3 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.1k citations) and Molecular Biology (3.4k citations). Petri Salvén has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Heikki Joensuu, Kari Alitalo, Arto Orpana, Lasse Teerenhovi, Päivi Heikkilä, Iiro Rajantie, Shahin Rafii, Riitta Alitalo, Tarja Ruotsalainen and Shentong Fang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.